New insights into the obesity paradox in renal cell carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://www.nature.com/articles/s41581-020-0264-y.pdf
Reference10 articles.
1. Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579–591 (2004).
2. Choueiri, T. K. et al. The impact of body mass index (BMI) and body surface area (BSA) on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: results from a large international collaboration. J. Clin. Oncol. 28 (Suppl. 15), 4524 (2010).
3. Cespedes Feliciano, E. M., Kroenke, C. H. & Caan, B. J. The obesity paradox in cancer: how important is muscle? Annu. Rev. Nutr. 38, 357–379 (2018).
4. Clark, A. L., Fonarow, G. C. & Horwich, T. B. Obesity and the obesity paradox in heart Ffailure. Prog. Cardiovasc. Dis. 56, 409–414 (2014).
5. Baracos, V. E. & Arribas, L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann. Oncol. 29 (Suppl. 2), ii1–ii9 (2018).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modulating Autophagy as an Attractive Strategy to Treat Renal Cell Carcinoma;Asian Science Bulletin;2024-12-31
2. Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis;Investigative and Clinical Urology;2024
3. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma;Cancer Genomics - Proteomics;2023
4. Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy;Clinical Genitourinary Cancer;2022-12
5. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets;Nature Reviews Urology;2022-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3